A new discovery involving two Simon Fraser University scientists could lead to a little known and benign bacterium becoming a vital new tool in the development of a vaccine against human immunodeficiency virus (HIV).
Â
Ralph Pantophlet, a Faculty of Health Sciences assistant professor, and Kate Auyeung, his senior research assistant and lab manager at SFU, and scientists in Italy have made a breakthrough discovery about Rhizobium radiobacter.
Â
The journal Chemistry & Biology has just published their research in its Feb. 24 issue.
Â
The research team has discovered this harmless bacterium has on its surface sugar molecules that resemble those on the surface of HIV. This resemblance gives scientists a basis for developing a preventive vaccine, putting our immune system on guard against HIV.
Â
HIVs sugar molecules act as a cloaking device, preventing our immune system from detecting the virus until it has created several variant generations of itself. By the time our immune systems recognition has kicked in, weeks have elapsed, and HIV is several steps ahead of our bodys efforts to eliminate it.
Â
Pantophlet and his colleagues believe the sugar molecules on Rhizobium radiobacter could be used to trigger our immune system to immediately recognize those on HIV, prompting more immediate awareness of the virus invasion.
Â
 The irony of our discovery is not lost on us, says Pantophlet. Weve found that a harmless species of a bacteria family that can cause tumours in the roots of legume plants could become a vital tool in the fight against one of the deadliest infectious diseases.
Â
Before Rhizobium radiobacter can become the basis of an anti-HIV vaccine, the scientists need to find a protein to which they can attach the bacteriums sugar molecules. The protein is needed to properly trigger our immune systems development of antibodies to the sugar molecules. Such antibodies would then recognize and target HIVs sugar molecules because they resemble those on the bacterium.
Â
This method of triggering antibodies development has led to the invention of successful sugar-based vaccines against diseases such as meningitis and childhood pneumonia.
Â
Two known proteins, tetanus toxoid and CRM197, a nontoxic recombinant variant of diphtheria toxin, are commonly used to develop these kinds of vaccines, explains Pantophlet. So a lot of the groundwork is there for us to be able to have a vaccine that could be tested in a lab first and then in clinical trials later on.
Â
Pantophlet and his colleagues are seeking grant funding from the Canadian Institutes for Health Research to continue their research.
Â
If they get the grant, they hope to attach Rhizobium radiobacters sugar molecules to a protein and create vaccine candidates for testing within the next one to two years
Â
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
US Withdrawal From UNESCO Signals a Dangerous Step Back for Global Science
July 22nd 2025In a decision heavy with consequence and light on foresight, the US has once again chosen to walk away from UNESCO, leaving behind not just a seat at the table, but a legacy of global scientific leadership that now lies in question.
Breaking the Cycle of Silence: Why Sharps Injuries Go Unreported and What Can Be Done
Published: July 24th 2025 | Updated: July 23rd 2025Despite decades of progress in health care safety, a quiet but dangerous culture still lingers: many health care workers remain afraid to report sharps injuries, fearing blame more than the wound itself.
Telemedicine's Transformative Role in PPE Distribution and Sterile Equipment Management
July 22nd 2025In an era defined by digital transformation and post-pandemic urgency, telemedicine has evolved beyond virtual visits to become a vital infrastructure for delivering personal protective equipment (PPE) and managing sterile supplies. By enabling real-time forecasting, remote quality control, and equitable distribution, telemedicine is revolutionizing how health care systems protect both patients and providers.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
US Withdrawal From UNESCO Signals a Dangerous Step Back for Global Science
July 22nd 2025In a decision heavy with consequence and light on foresight, the US has once again chosen to walk away from UNESCO, leaving behind not just a seat at the table, but a legacy of global scientific leadership that now lies in question.
Breaking the Cycle of Silence: Why Sharps Injuries Go Unreported and What Can Be Done
Published: July 24th 2025 | Updated: July 23rd 2025Despite decades of progress in health care safety, a quiet but dangerous culture still lingers: many health care workers remain afraid to report sharps injuries, fearing blame more than the wound itself.
Telemedicine's Transformative Role in PPE Distribution and Sterile Equipment Management
July 22nd 2025In an era defined by digital transformation and post-pandemic urgency, telemedicine has evolved beyond virtual visits to become a vital infrastructure for delivering personal protective equipment (PPE) and managing sterile supplies. By enabling real-time forecasting, remote quality control, and equitable distribution, telemedicine is revolutionizing how health care systems protect both patients and providers.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
2 Commerce Drive
Cranbury, NJ 08512